Pharma & Healthcare
Global Recombinant Proteins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 438253
- Pages: 99
- Figures: 96
- Views: 4
The global Recombinant Proteins market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
By Type: (Dominant Segment vs High-Margin Innovation)
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Bio-Techne Corporation in Europe)
- Emerging Product Trends: Hormones adoption vs. Growth Factors premiumization
- Demand-Side Dynamics: Biopharmaceutical Companies growth in China vs. Academic and Research Institutes potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Middle East
India
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Recombinant Proteins market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Growth Factors in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Academic and Research Institutes in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Proteins value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Market Segmentation
By Company:
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
By Type: (Dominant Segment vs High-Margin Innovation)
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Bio-Techne Corporation in Europe)
- Emerging Product Trends: Hormones adoption vs. Growth Factors premiumization
- Demand-Side Dynamics: Biopharmaceutical Companies growth in China vs. Academic and Research Institutes potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Middle East
India
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Recombinant Proteins market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Growth Factors in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Academic and Research Institutes in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Recombinant Proteins value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Proteins Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Recombinant Proteins Revenue Market Share by Region (2020-2025)
2.4 Global Recombinant Proteins Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.2 Europe Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.3 China Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.4 Japan Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.5 Middle East Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.6 India Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.7 Central & South America Recombinant Proteins Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Recombinant Proteins Historic Market Size by Type (2020-2025)
3.2 Global Recombinant Proteins Forecasted Market Size by Type (2026-2031)
3.3 Different Types Recombinant Proteins Representative Players
4 Breakdown Data by Application
4.1 Global Recombinant Proteins Historic Market Size by Application (2020-2025)
4.2 Global Recombinant Proteins Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Recombinant Proteins Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Recombinant Proteins Players by Revenue (2020-2025)
5.1.2 Global Recombinant Proteins Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Recombinant Proteins Revenue
5.4 Global Recombinant Proteins Market Concentration Analysis
5.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2024
5.5 Global Key Players of Recombinant Proteins Head office and Area Served
5.6 Global Key Players of Recombinant Proteins, Product and Application
5.7 Global Key Players of Recombinant Proteins, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Recombinant Proteins Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Recombinant Proteins Market Size by Type (2020-2025)
6.1.2.2 North America Recombinant Proteins Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Recombinant Proteins Market Size by Application (2020-2025)
6.1.3.2 North America Recombinant Proteins Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Recombinant Proteins Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Recombinant Proteins Market Size by Type (2020-2025)
6.2.2.2 Europe Recombinant Proteins Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Recombinant Proteins Market Size by Application (2020-2025)
6.2.3.2 Europe Recombinant Proteins Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Recombinant Proteins Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Recombinant Proteins Market Size by Type (2020-2025)
6.3.2.2 China Recombinant Proteins Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Recombinant Proteins Market Size by Application (2020-2025)
6.3.3.2 China Recombinant Proteins Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Recombinant Proteins Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Recombinant Proteins Market Size by Type (2020-2025)
6.4.2.2 Japan Recombinant Proteins Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Recombinant Proteins Market Size by Application (2020-2025)
6.4.3.2 Japan Recombinant Proteins Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Middle East Market: Players, Segments and Downstream
6.5.1 Middle East Recombinant Proteins Revenue by Company (2020-2025)
6.5.2 Middle East Market Size by Type
6.5.2.1 Middle East Recombinant Proteins Market Size by Type (2020-2025)
6.5.2.2 Middle East Recombinant Proteins Market Share by Type (2020-2025)
6.5.3 Middle East Market Size by Application
6.5.3.1 Middle East Recombinant Proteins Market Size by Application (2020-2025)
6.5.3.2 Middle East Recombinant Proteins Market Share by Application (2020-2025)
6.5.4 Middle East Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Recombinant Proteins Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Recombinant Proteins Market Size by Type (2020-2025)
6.6.2.2 India Recombinant Proteins Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Recombinant Proteins Market Size by Application (2020-2025)
6.6.3.2 India Recombinant Proteins Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Bio-Techne Corporation
7.1.1 Bio-Techne Corporation Company Details
7.1.2 Bio-Techne Corporation Business Overview
7.1.3 Bio-Techne Corporation Recombinant Proteins Introduction
7.1.4 Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025)
7.1.5 Bio-Techne Corporation Recent Development
7.2 Abcam PLC
7.2.1 Abcam PLC Company Details
7.2.2 Abcam PLC Business Overview
7.2.3 Abcam PLC Recombinant Proteins Introduction
7.2.4 Abcam PLC Revenue in Recombinant Proteins Business (2020-2025)
7.2.5 Abcam PLC Recent Development
7.3 Merck KGaA
7.3.1 Merck KGaA Company Details
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Recombinant Proteins Introduction
7.3.4 Merck KGaA Revenue in Recombinant Proteins Business (2020-2025)
7.3.5 Merck KGaA Recent Development
7.4 Miltenyi Biotec
7.4.1 Miltenyi Biotec Company Details
7.4.2 Miltenyi Biotec Business Overview
7.4.3 Miltenyi Biotec Recombinant Proteins Introduction
7.4.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025)
7.4.5 Miltenyi Biotec Recent Development
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Details
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Recombinant Proteins Introduction
7.5.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025)
7.5.5 Thermo Fisher Scientific Recent Development
7.6 ACROBiosystems
7.6.1 ACROBiosystems Company Details
7.6.2 ACROBiosystems Business Overview
7.6.3 ACROBiosystems Recombinant Proteins Introduction
7.6.4 ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025)
7.6.5 ACROBiosystems Recent Development
7.7 Sino Biological
7.7.1 Sino Biological Company Details
7.7.2 Sino Biological Business Overview
7.7.3 Sino Biological Recombinant Proteins Introduction
7.7.4 Sino Biological Revenue in Recombinant Proteins Business (2020-2025)
7.7.5 Sino Biological Recent Development
7.8 Cytiva
7.8.1 Cytiva Company Details
7.8.2 Cytiva Business Overview
7.8.3 Cytiva Recombinant Proteins Introduction
7.8.4 Cytiva Revenue in Recombinant Proteins Business (2020-2025)
7.8.5 Cytiva Recent Development
7.9 Eurogentec
7.9.1 Eurogentec Company Details
7.9.2 Eurogentec Business Overview
7.9.3 Eurogentec Recombinant Proteins Introduction
7.9.4 Eurogentec Revenue in Recombinant Proteins Business (2020-2025)
7.9.5 Eurogentec Recent Development
7.10 GenScript Biotech Corporation
7.10.1 GenScript Biotech Corporation Company Details
7.10.2 GenScript Biotech Corporation Business Overview
7.10.3 GenScript Biotech Corporation Recombinant Proteins Introduction
7.10.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025)
7.10.5 GenScript Biotech Corporation Recent Development
7.11 Reprocell
7.11.1 Reprocell Company Details
7.11.2 Reprocell Business Overview
7.11.3 Reprocell Recombinant Proteins Introduction
7.11.4 Reprocell Revenue in Recombinant Proteins Business (2020-2025)
7.11.5 Reprocell Recent Development
7.12 BPS Bioscience
7.12.1 BPS Bioscience Company Details
7.12.2 BPS Bioscience Business Overview
7.12.3 BPS Bioscience Recombinant Proteins Introduction
7.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025)
7.12.5 BPS Bioscience Recent Development
7.13 Abnova Corporation
7.13.1 Abnova Corporation Company Details
7.13.2 Abnova Corporation Business Overview
7.13.3 Abnova Corporation Recombinant Proteins Introduction
7.13.4 Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025)
7.13.5 Abnova Corporation Recent Development
7.14 ProSpec Tany TechnoGene
7.14.1 ProSpec Tany TechnoGene Company Details
7.14.2 ProSpec Tany TechnoGene Business Overview
7.14.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
7.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025)
7.14.5 ProSpec Tany TechnoGene Recent Development
7.15 Ajinomoto
7.15.1 Ajinomoto Company Details
7.15.2 Ajinomoto Business Overview
7.15.3 Ajinomoto Recombinant Proteins Introduction
7.15.4 Ajinomoto Revenue in Recombinant Proteins Business (2020-2025)
7.15.5 Ajinomoto Recent Development
8 Recombinant Proteins Market Dynamics
8.1 Recombinant Proteins Industry Trends
8.2 Recombinant Proteins Market Drivers
8.3 Recombinant Proteins Market Challenges
8.4 Recombinant Proteins Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Proteins Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Recombinant Proteins Revenue Market Share by Region (2020-2025)
2.4 Global Recombinant Proteins Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.2 Europe Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.3 China Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.4 Japan Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.5 Middle East Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.6 India Recombinant Proteins Market Size and Prospective (2020-2031)
2.5.7 Central & South America Recombinant Proteins Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Recombinant Proteins Historic Market Size by Type (2020-2025)
3.2 Global Recombinant Proteins Forecasted Market Size by Type (2026-2031)
3.3 Different Types Recombinant Proteins Representative Players
4 Breakdown Data by Application
4.1 Global Recombinant Proteins Historic Market Size by Application (2020-2025)
4.2 Global Recombinant Proteins Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Recombinant Proteins Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Recombinant Proteins Players by Revenue (2020-2025)
5.1.2 Global Recombinant Proteins Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Recombinant Proteins Revenue
5.4 Global Recombinant Proteins Market Concentration Analysis
5.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2024
5.5 Global Key Players of Recombinant Proteins Head office and Area Served
5.6 Global Key Players of Recombinant Proteins, Product and Application
5.7 Global Key Players of Recombinant Proteins, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Recombinant Proteins Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Recombinant Proteins Market Size by Type (2020-2025)
6.1.2.2 North America Recombinant Proteins Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Recombinant Proteins Market Size by Application (2020-2025)
6.1.3.2 North America Recombinant Proteins Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Recombinant Proteins Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Recombinant Proteins Market Size by Type (2020-2025)
6.2.2.2 Europe Recombinant Proteins Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Recombinant Proteins Market Size by Application (2020-2025)
6.2.3.2 Europe Recombinant Proteins Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Recombinant Proteins Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Recombinant Proteins Market Size by Type (2020-2025)
6.3.2.2 China Recombinant Proteins Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Recombinant Proteins Market Size by Application (2020-2025)
6.3.3.2 China Recombinant Proteins Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Recombinant Proteins Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Recombinant Proteins Market Size by Type (2020-2025)
6.4.2.2 Japan Recombinant Proteins Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Recombinant Proteins Market Size by Application (2020-2025)
6.4.3.2 Japan Recombinant Proteins Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Middle East Market: Players, Segments and Downstream
6.5.1 Middle East Recombinant Proteins Revenue by Company (2020-2025)
6.5.2 Middle East Market Size by Type
6.5.2.1 Middle East Recombinant Proteins Market Size by Type (2020-2025)
6.5.2.2 Middle East Recombinant Proteins Market Share by Type (2020-2025)
6.5.3 Middle East Market Size by Application
6.5.3.1 Middle East Recombinant Proteins Market Size by Application (2020-2025)
6.5.3.2 Middle East Recombinant Proteins Market Share by Application (2020-2025)
6.5.4 Middle East Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Recombinant Proteins Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Recombinant Proteins Market Size by Type (2020-2025)
6.6.2.2 India Recombinant Proteins Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Recombinant Proteins Market Size by Application (2020-2025)
6.6.3.2 India Recombinant Proteins Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Bio-Techne Corporation
7.1.1 Bio-Techne Corporation Company Details
7.1.2 Bio-Techne Corporation Business Overview
7.1.3 Bio-Techne Corporation Recombinant Proteins Introduction
7.1.4 Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025)
7.1.5 Bio-Techne Corporation Recent Development
7.2 Abcam PLC
7.2.1 Abcam PLC Company Details
7.2.2 Abcam PLC Business Overview
7.2.3 Abcam PLC Recombinant Proteins Introduction
7.2.4 Abcam PLC Revenue in Recombinant Proteins Business (2020-2025)
7.2.5 Abcam PLC Recent Development
7.3 Merck KGaA
7.3.1 Merck KGaA Company Details
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Recombinant Proteins Introduction
7.3.4 Merck KGaA Revenue in Recombinant Proteins Business (2020-2025)
7.3.5 Merck KGaA Recent Development
7.4 Miltenyi Biotec
7.4.1 Miltenyi Biotec Company Details
7.4.2 Miltenyi Biotec Business Overview
7.4.3 Miltenyi Biotec Recombinant Proteins Introduction
7.4.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025)
7.4.5 Miltenyi Biotec Recent Development
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Details
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Recombinant Proteins Introduction
7.5.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025)
7.5.5 Thermo Fisher Scientific Recent Development
7.6 ACROBiosystems
7.6.1 ACROBiosystems Company Details
7.6.2 ACROBiosystems Business Overview
7.6.3 ACROBiosystems Recombinant Proteins Introduction
7.6.4 ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025)
7.6.5 ACROBiosystems Recent Development
7.7 Sino Biological
7.7.1 Sino Biological Company Details
7.7.2 Sino Biological Business Overview
7.7.3 Sino Biological Recombinant Proteins Introduction
7.7.4 Sino Biological Revenue in Recombinant Proteins Business (2020-2025)
7.7.5 Sino Biological Recent Development
7.8 Cytiva
7.8.1 Cytiva Company Details
7.8.2 Cytiva Business Overview
7.8.3 Cytiva Recombinant Proteins Introduction
7.8.4 Cytiva Revenue in Recombinant Proteins Business (2020-2025)
7.8.5 Cytiva Recent Development
7.9 Eurogentec
7.9.1 Eurogentec Company Details
7.9.2 Eurogentec Business Overview
7.9.3 Eurogentec Recombinant Proteins Introduction
7.9.4 Eurogentec Revenue in Recombinant Proteins Business (2020-2025)
7.9.5 Eurogentec Recent Development
7.10 GenScript Biotech Corporation
7.10.1 GenScript Biotech Corporation Company Details
7.10.2 GenScript Biotech Corporation Business Overview
7.10.3 GenScript Biotech Corporation Recombinant Proteins Introduction
7.10.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025)
7.10.5 GenScript Biotech Corporation Recent Development
7.11 Reprocell
7.11.1 Reprocell Company Details
7.11.2 Reprocell Business Overview
7.11.3 Reprocell Recombinant Proteins Introduction
7.11.4 Reprocell Revenue in Recombinant Proteins Business (2020-2025)
7.11.5 Reprocell Recent Development
7.12 BPS Bioscience
7.12.1 BPS Bioscience Company Details
7.12.2 BPS Bioscience Business Overview
7.12.3 BPS Bioscience Recombinant Proteins Introduction
7.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025)
7.12.5 BPS Bioscience Recent Development
7.13 Abnova Corporation
7.13.1 Abnova Corporation Company Details
7.13.2 Abnova Corporation Business Overview
7.13.3 Abnova Corporation Recombinant Proteins Introduction
7.13.4 Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025)
7.13.5 Abnova Corporation Recent Development
7.14 ProSpec Tany TechnoGene
7.14.1 ProSpec Tany TechnoGene Company Details
7.14.2 ProSpec Tany TechnoGene Business Overview
7.14.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
7.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025)
7.14.5 ProSpec Tany TechnoGene Recent Development
7.15 Ajinomoto
7.15.1 Ajinomoto Company Details
7.15.2 Ajinomoto Business Overview
7.15.3 Ajinomoto Recombinant Proteins Introduction
7.15.4 Ajinomoto Revenue in Recombinant Proteins Business (2020-2025)
7.15.5 Ajinomoto Recent Development
8 Recombinant Proteins Market Dynamics
8.1 Recombinant Proteins Industry Trends
8.2 Recombinant Proteins Market Drivers
8.3 Recombinant Proteins Market Challenges
8.4 Recombinant Proteins Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Recombinant Proteins Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Recombinant Proteins Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Recombinant Proteins Revenue Share by Region (2020-2025)
Table 6. Global Recombinant Proteins Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Recombinant Proteins Revenue Share Forecast by Region (2026-2031)
Table 8. Global Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Recombinant Proteins Revenue Market Share by Type (2020-2025)
Table 10. Global Recombinant Proteins Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Recombinant Proteins Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Recombinant Proteins Revenue Market Share by Application (2020-2025)
Table 15. Global Recombinant Proteins Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Recombinant Proteins Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Recombinant Proteins Application
Table 18. Global Recombinant Proteins Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Recombinant Proteins Market Share by Players (2020-2025)
Table 20. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Table 21. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Recombinant Proteins, Headquarters and Area Served
Table 24. Global Key Players of Recombinant Proteins, Product and Application
Table 25. Global Key Players of Recombinant Proteins, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 29. North America Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 33. Europe Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 37. China Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 41. Japan Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 45. Middle East Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 49. India Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 51. Bio-Techne Corporation Company Details
Table 52. Bio-Techne Corporation Business Overview
Table 53. Bio-Techne Corporation Recombinant Proteins Product
Table 54. Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 55. Bio-Techne Corporation Recent Development
Table 56. Abcam PLC Company Details
Table 57. Abcam PLC Business Overview
Table 58. Abcam PLC Recombinant Proteins Product
Table 59. Abcam PLC Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 60. Abcam PLC Recent Development
Table 61. Merck KGaA Company Details
Table 62. Merck KGaA Business Overview
Table 63. Merck KGaA Recombinant Proteins Product
Table 64. Merck KGaA Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 65. Merck KGaA Recent Development
Table 66. Miltenyi Biotec Company Details
Table 67. Miltenyi Biotec Business Overview
Table 68. Miltenyi Biotec Recombinant Proteins Product
Table 69. Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 70. Miltenyi Biotec Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Recombinant Proteins Product
Table 74. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. ACROBiosystems Company Details
Table 77. ACROBiosystems Business Overview
Table 78. ACROBiosystems Recombinant Proteins Product
Table 79. ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 80. ACROBiosystems Recent Development
Table 81. Sino Biological Company Details
Table 82. Sino Biological Business Overview
Table 83. Sino Biological Recombinant Proteins Product
Table 84. Sino Biological Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 85. Sino Biological Recent Development
Table 86. Cytiva Company Details
Table 87. Cytiva Business Overview
Table 88. Cytiva Recombinant Proteins Product
Table 89. Cytiva Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 90. Cytiva Recent Development
Table 91. Eurogentec Company Details
Table 92. Eurogentec Business Overview
Table 93. Eurogentec Recombinant Proteins Product
Table 94. Eurogentec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 95. Eurogentec Recent Development
Table 96. GenScript Biotech Corporation Company Details
Table 97. GenScript Biotech Corporation Business Overview
Table 98. GenScript Biotech Corporation Recombinant Proteins Product
Table 99. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 100. GenScript Biotech Corporation Recent Development
Table 101. Reprocell Company Details
Table 102. Reprocell Business Overview
Table 103. Reprocell Recombinant Proteins Product
Table 104. Reprocell Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 105. Reprocell Recent Development
Table 106. BPS Bioscience Company Details
Table 107. BPS Bioscience Business Overview
Table 108. BPS Bioscience Recombinant Proteins Product
Table 109. BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 110. BPS Bioscience Recent Development
Table 111. Abnova Corporation Company Details
Table 112. Abnova Corporation Business Overview
Table 113. Abnova Corporation Recombinant Proteins Product
Table 114. Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 115. Abnova Corporation Recent Development
Table 116. ProSpec Tany TechnoGene Company Details
Table 117. ProSpec Tany TechnoGene Business Overview
Table 118. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 119. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 120. ProSpec Tany TechnoGene Recent Development
Table 121. Ajinomoto Company Details
Table 122. Ajinomoto Business Overview
Table 123. Ajinomoto Recombinant Proteins Product
Table 124. Ajinomoto Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 125. Ajinomoto Recent Development
Table 126. Recombinant Proteins Market Trends
Table 127. Recombinant Proteins Market Drivers
Table 128. Recombinant Proteins Market Challenges
Table 129. Recombinant Proteins Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Proteins Product Picture
Figure 2. Global Recombinant Proteins Market Share by Type: 2024 VS 2031
Figure 3. Hormones Features
Figure 4. Growth Factors Features
Figure 5. Cytokines Features
Figure 6. Plasma Protein Factor Features
Figure 7. Recombinant Metabolic Enzymes Features
Figure 8. Immune Checkpoint Regulators Features
Figure 9. Others Features
Figure 10. Global Recombinant Proteins Market Share by Application: 2024 VS 2031
Figure 11. Biopharmaceutical Companies
Figure 12. Academic and Research Institutes
Figure 13. Contract Research Organizations
Figure 14. Recombinant Proteins Report Years Considered
Figure 15. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Recombinant Proteins Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Recombinant Proteins Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Europe Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. China Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Japan Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Middle East Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. India Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Central & South America Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Global Recombinant Proteins Market Share by Players in 2024
Figure 26. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Figure 27. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2024
Figure 28. North America Recombinant Proteins Market Share by Type (2020-2025)
Figure 29. North America Recombinant Proteins Market Share by Application (2020-2025)
Figure 30. Europe Recombinant Proteins Market Share by Type (2020-2025)
Figure 31. Europe Recombinant Proteins Market Share by Application (2020-2025)
Figure 32. China Recombinant Proteins Market Share by Type (2020-2025)
Figure 33. China Recombinant Proteins Market Share by Application (2020-2025)
Figure 34. Japan Recombinant Proteins Market Share by Type (2020-2025)
Figure 35. Japan Recombinant Proteins Market Share by Application (2020-2025)
Figure 36. Middle East Recombinant Proteins Market Share by Type (2020-2025)
Figure 37. Middle East Recombinant Proteins Market Share by Application (2020-2025)
Figure 38. India Recombinant Proteins Market Share by Type (2020-2025)
Figure 39. India Recombinant Proteins Market Share by Application (2020-2025)
Figure 40. Bio-Techne Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 41. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 42. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 43. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 44. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 45. ACROBiosystems Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 46. Sino Biological Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 47. Cytiva Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 48. Eurogentec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 49. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 50. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 51. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 52. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 53. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 54. Ajinomoto Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Recombinant Proteins Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Recombinant Proteins Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Recombinant Proteins Revenue Share by Region (2020-2025)
Table 6. Global Recombinant Proteins Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Recombinant Proteins Revenue Share Forecast by Region (2026-2031)
Table 8. Global Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Recombinant Proteins Revenue Market Share by Type (2020-2025)
Table 10. Global Recombinant Proteins Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Recombinant Proteins Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Recombinant Proteins Revenue Market Share by Application (2020-2025)
Table 15. Global Recombinant Proteins Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Recombinant Proteins Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Recombinant Proteins Application
Table 18. Global Recombinant Proteins Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Recombinant Proteins Market Share by Players (2020-2025)
Table 20. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Table 21. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Recombinant Proteins, Headquarters and Area Served
Table 24. Global Key Players of Recombinant Proteins, Product and Application
Table 25. Global Key Players of Recombinant Proteins, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 29. North America Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 33. Europe Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 37. China Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 41. Japan Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 45. Middle East Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Recombinant Proteins Revenue Market Share by Company (2020-2025)
Table 49. India Recombinant Proteins Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Recombinant Proteins Market Size by Application (2020-2025) & (US$ Million)
Table 51. Bio-Techne Corporation Company Details
Table 52. Bio-Techne Corporation Business Overview
Table 53. Bio-Techne Corporation Recombinant Proteins Product
Table 54. Bio-Techne Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 55. Bio-Techne Corporation Recent Development
Table 56. Abcam PLC Company Details
Table 57. Abcam PLC Business Overview
Table 58. Abcam PLC Recombinant Proteins Product
Table 59. Abcam PLC Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 60. Abcam PLC Recent Development
Table 61. Merck KGaA Company Details
Table 62. Merck KGaA Business Overview
Table 63. Merck KGaA Recombinant Proteins Product
Table 64. Merck KGaA Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 65. Merck KGaA Recent Development
Table 66. Miltenyi Biotec Company Details
Table 67. Miltenyi Biotec Business Overview
Table 68. Miltenyi Biotec Recombinant Proteins Product
Table 69. Miltenyi Biotec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 70. Miltenyi Biotec Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Recombinant Proteins Product
Table 74. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. ACROBiosystems Company Details
Table 77. ACROBiosystems Business Overview
Table 78. ACROBiosystems Recombinant Proteins Product
Table 79. ACROBiosystems Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 80. ACROBiosystems Recent Development
Table 81. Sino Biological Company Details
Table 82. Sino Biological Business Overview
Table 83. Sino Biological Recombinant Proteins Product
Table 84. Sino Biological Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 85. Sino Biological Recent Development
Table 86. Cytiva Company Details
Table 87. Cytiva Business Overview
Table 88. Cytiva Recombinant Proteins Product
Table 89. Cytiva Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 90. Cytiva Recent Development
Table 91. Eurogentec Company Details
Table 92. Eurogentec Business Overview
Table 93. Eurogentec Recombinant Proteins Product
Table 94. Eurogentec Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 95. Eurogentec Recent Development
Table 96. GenScript Biotech Corporation Company Details
Table 97. GenScript Biotech Corporation Business Overview
Table 98. GenScript Biotech Corporation Recombinant Proteins Product
Table 99. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 100. GenScript Biotech Corporation Recent Development
Table 101. Reprocell Company Details
Table 102. Reprocell Business Overview
Table 103. Reprocell Recombinant Proteins Product
Table 104. Reprocell Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 105. Reprocell Recent Development
Table 106. BPS Bioscience Company Details
Table 107. BPS Bioscience Business Overview
Table 108. BPS Bioscience Recombinant Proteins Product
Table 109. BPS Bioscience Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 110. BPS Bioscience Recent Development
Table 111. Abnova Corporation Company Details
Table 112. Abnova Corporation Business Overview
Table 113. Abnova Corporation Recombinant Proteins Product
Table 114. Abnova Corporation Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 115. Abnova Corporation Recent Development
Table 116. ProSpec Tany TechnoGene Company Details
Table 117. ProSpec Tany TechnoGene Business Overview
Table 118. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 119. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 120. ProSpec Tany TechnoGene Recent Development
Table 121. Ajinomoto Company Details
Table 122. Ajinomoto Business Overview
Table 123. Ajinomoto Recombinant Proteins Product
Table 124. Ajinomoto Revenue in Recombinant Proteins Business (2020-2025) & (US$ Million)
Table 125. Ajinomoto Recent Development
Table 126. Recombinant Proteins Market Trends
Table 127. Recombinant Proteins Market Drivers
Table 128. Recombinant Proteins Market Challenges
Table 129. Recombinant Proteins Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Proteins Product Picture
Figure 2. Global Recombinant Proteins Market Share by Type: 2024 VS 2031
Figure 3. Hormones Features
Figure 4. Growth Factors Features
Figure 5. Cytokines Features
Figure 6. Plasma Protein Factor Features
Figure 7. Recombinant Metabolic Enzymes Features
Figure 8. Immune Checkpoint Regulators Features
Figure 9. Others Features
Figure 10. Global Recombinant Proteins Market Share by Application: 2024 VS 2031
Figure 11. Biopharmaceutical Companies
Figure 12. Academic and Research Institutes
Figure 13. Contract Research Organizations
Figure 14. Recombinant Proteins Report Years Considered
Figure 15. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Recombinant Proteins Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Recombinant Proteins Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Europe Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. China Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Japan Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Middle East Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. India Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Central & South America Recombinant Proteins Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Global Recombinant Proteins Market Share by Players in 2024
Figure 26. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
Figure 27. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2024
Figure 28. North America Recombinant Proteins Market Share by Type (2020-2025)
Figure 29. North America Recombinant Proteins Market Share by Application (2020-2025)
Figure 30. Europe Recombinant Proteins Market Share by Type (2020-2025)
Figure 31. Europe Recombinant Proteins Market Share by Application (2020-2025)
Figure 32. China Recombinant Proteins Market Share by Type (2020-2025)
Figure 33. China Recombinant Proteins Market Share by Application (2020-2025)
Figure 34. Japan Recombinant Proteins Market Share by Type (2020-2025)
Figure 35. Japan Recombinant Proteins Market Share by Application (2020-2025)
Figure 36. Middle East Recombinant Proteins Market Share by Type (2020-2025)
Figure 37. Middle East Recombinant Proteins Market Share by Application (2020-2025)
Figure 38. India Recombinant Proteins Market Share by Type (2020-2025)
Figure 39. India Recombinant Proteins Market Share by Application (2020-2025)
Figure 40. Bio-Techne Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 41. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 42. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 43. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 44. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 45. ACROBiosystems Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 46. Sino Biological Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 47. Cytiva Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 48. Eurogentec Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 49. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 50. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 51. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 52. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 53. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 54. Ajinomoto Revenue Growth Rate in Recombinant Proteins Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232